Skip to main content
. 2019 May 21;11(5):242. doi: 10.3390/pharmaceutics11050242

Figure 3.

Figure 3

Characterizations of the nanoparticles (NPs). (A) Fourier transform infrared (FT-IR) spectrum of the BPQDs-based nanoparticles. (B) Raman spectra of the NPs. (C) X-ray photoelectron spectroscopy (XPS) spectrum of BPQDs-PEG-FA/DOX. (D) DOX release profiles of BPQDs-PEG-FA/DOX at different pH values with or without near infrared laser irradiation (1.0 W cm−2, 6 min).